> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Reopens Comments on Drug Supply Security
- URL: https://www.fdaweb.com/fda-reopens-comments-on-drug-supply-security/
- Published: 2017-05-02T12:00:00.000Z
- Updated: 2026-09-14T22:21:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138592

*Federal Register* notice: FDA has reopened the comment period regarding issues related to utilizing the product identifier for product tracing, improving the technical capabilities of the supply chain, and identifying system attributes that are necessary to implement the requirements established under the Drug Supply Chain Security Act (DSCSA). The information gathered from additional public comments will help with the design and development of pilot projects that FDA establishes under the DSCSA. Comments are now being received until 4/30/2018\. to view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-04-28/pdf/2017-08583.pdf?ref=fdaweb.com).